Chemical classes that act as indirect inhibitors of a protein like C15orf61 operate by modulating various cellular pathways that can influence the protein's function or expression. These chemicals can have diverse structures and target different components of cellular machinery. For example, kinase inhibitors, such as staurosporine, can affect the phosphorylation status of numerous proteins, altering the activity of a protein like C15orf61 if it is regulated by phosphorylation. Similarly, compounds like rapamycin and LY294002 act on the mTOR and PI3K signaling pathways, respectively, which are critical for regulating cell growth, proliferation, and survival, and may indirectly affect proteins that are downstream of these pathways.
On the other hand, chemicals like cycloheximide and 5-Azacytidine affect protein synthesis and gene expression. Cycloheximide achieves this by halting mRNA translation, thereby reducing the overall protein levels within a cell, which could include C15orf61. 5-Azacytidine, on the other hand, inhibits DNA methyltransferases, leading to reactivation of silenced genes and alteration of gene expression profiles, which could change the expression levels of C15orf61. Histone deacetylase inhibitors like Trichostatin A modify the chromatin structure, leading to changes in gene expression that can also affect the levels of C15orf61. Proteasome inhibitors such as MG132 interfere with protein degradation pathways, possibly resultingin increased levels of proteins, including unstable proteins like C15orf61. Lastly, chemicals affecting intracellular trafficking, such as Brefeldin A, disrupt protein localization and function, which might influence how C15orf61 interacts within the cell.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A known kinase inhibitor that can affect multiple signaling pathways by inhibiting protein kinases that might regulate C15orf61 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can impact protein synthesis, potentially altering the expression or function of C15orf61 indirectly. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis which might reduce the overall levels of C15orf61 if it is a rapidly turned over protein. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can alter gene expression patterns, possibly affecting C15orf61 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that can change chromatin structure and gene expression, potentially influencing C15orf61 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can modify signaling pathways, potentially altering the activity or levels of C15orf61 as a downstream effect. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), which can affect signaling pathways that may include C15orf61-related processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that can alter MAPK/ERK signaling pathways, potentially influencing C15orf61 activity indirectly. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Another MEK inhibitor similar to PD98059 that can affect the MAPK/ERK pathway and consequently, the activity of C15orf61. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can increase protein levels by inhibiting degradation, potentially affecting C15orf61 levels. | ||||||